Sarepta Therapeutics, Inc. (SRPT): Price and Financial Metrics

SRPT POWR Grades

• Growth is the dimension where SRPT ranks best; there it ranks ahead of 95.36% of US stocks.
• The strongest trend for SRPT is in Growth, which has been heading up over the past 179 days.
• SRPT ranks lowest in Momentum; there it ranks in the 12th percentile.

SRPT Stock Summary

• Of note is the ratio of Sarepta Therapeutics Inc's sales and general administrative expense to its total operating expenses; merely 11.72% of US stocks have a lower such ratio.
• With a price/sales ratio of 9.77, Sarepta Therapeutics Inc has a higher such ratio than 84.94% of stocks in our set.
• Equity multiplier, or assets relative to shareholders' equity, comes in at 4.69 for Sarepta Therapeutics Inc; that's greater than it is for 78.03% of US stocks.
• Stocks with similar financial metrics, market capitalization, and price volatility to Sarepta Therapeutics Inc are CGEN, IDYA, WVE, PLRX, and PRQR.
• Visit SRPT's SEC page to see the company's official filings. To visit the company's web site, go to www.sarepta.com.

SRPT Valuation Summary

• In comparison to the median Healthcare stock, SRPT's price/sales ratio is 8.37% lower, now standing at 10.4.
• SRPT's price/earnings ratio has moved up 3.9 over the prior 243 months.
• SRPT's price/sales ratio has moved down 648 over the prior 243 months.

Below are key valuation metrics over time for SRPT.

SRPT Growth Metrics

Its year over year cash and equivalents growth rate is now at -16.01%.
• Its 4 year cash and equivalents growth rate is now at 4448.81%.
• The 5 year net cashflow from operations growth rate now stands at 290.38%.

Over the past 34 months, SRPT's revenue has gone up $378,446,000.

The table below shows SRPT's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	701.887	-443.172	-418.78
2021-09-30	645.564	-588.381	-486.116
2021-06-30	600.082	-702.238	-634.471
2021-03-31	573.356	-700.695	-703.886
2020-12-31	540.099	107.466	-554.128
2020-09-30	495.074	118.206	-600.514

SRPT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• SRPT has a Quality Grade of C, ranking ahead of 59.75% of graded US stocks.
• SRPT's asset turnover comes in at 0.231 -- ranking 185th of 682 Pharmaceutical Products stocks.
• ORMP, AGIO, and JAZZ are the stocks whose asset turnover ratios are most correlated with SRPT.

The table below shows SRPT's key quality metrics over time.